Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychiatric research Vol. 144; pp. 129 - 137
Main Authors: Renaud-Charest, Olivier, Lui, Leanna M.W., Eskander, Sherry, Ceban, Felicia, Ho, Roger, Di Vincenzo, Joshua D., Rosenblat, Joshua D., Lee, Yena, Subramaniapillai, Mehala, McIntyre, Roger S.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01.12.2021
Subjects:
COVID-19
COVID-19 - complications
Depression
Depression - epidemiology
Depression - etiology
Humans
Population health
Post-Acute COVID-19 Syndrome
Post-acute sequelae of COVID-19
Post-COVID-19 syndrome
Prospective Studies
SARS-CoV-2
COVID-19
Depression
SARS-CoV-2
Post-acute sequelae of COVID-19
Post-COVID-19 syndrome
Population health
ISSN:0022-3956, 1879-1379, 1879-1379
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute phase of COVID-19 have been well characterized, the frequency of depression following recovery of the acute phase remains unknown. Herein, we sought to determine the frequency of depressive symptoms and clinically-significant depression more than 12 weeks following SARS-CoV-2 infection. A systematic search of PubMed, Ovid Medline and Google Scholar for studies published between January 1, 2020 and June 5, 2021 was conducted. Frequency and factors associated with depression in post-COVID-19 syndrome were recorded and qualitatively assessed through narrative synthesis. Methodological quality and risk of bias was assessed using a modified version of the Newcastle-Ottawa Scale (NOS) for prospective cohort studies. Of 316 articles identified through our systematic search, eight studies were included. The frequency of depressive symptoms +12 weeks following SARS-CoV-2 infection ranged from 11 to 28%. The frequency of clinically-significant depression and/or severe depressive symptoms ranged from 3 to 12%. The severity of acute COVID-19 was not associated with the frequency of depressive symptoms. However, the component studies were highly heterogeneous with respect to mode of ascertainment, time of assessment, and location and age of patients. The majority of studies did not include an unexposed control group. Future research should endeavour to produce a standardized classification of post-COVID-19 syndrome, and as well as include unexposed control groups.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
ISSN:0022-3956
1879-1379
1879-1379
DOI:10.1016/j.jpsychires.2021.09.054